Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
237.1 CHF | +0.98% | +4.08% | -3.03% |
07:39am | Roche's Inavolisib Breast Cancer Treatment Gets FDA Breakthrough Therapy Designation | DJ |
07:37am | Roche's Investigational Breast Cancer Treatment Granted Breakthrough Designation by US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.03% | 210B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
+10.02% | 209B | |
+9.21% | 169B | |
-0.90% | 162B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial